Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05089149

Chronic Heart Failure - COngestion eValuation

Led by Pr. Nicolas GIRERD · Updated on 2023-06-05

200

Participants Needed

2

Research Sites

391 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of hospitalization for HF. Furthermore, congestive signs identified in asymptomatic patients are associated with the risk of developing symptomatic HF. The literature supports a multi-modality / integrative evaluation of congestion, combining clinical examination, laboratory results and ultrasound evaluation. The main objective of the CHF-COV study is to identify congestion markers (clinical, biological and ultrasound) quantified during a consultation or day hospitalization for the monitoring of chronic HF that are associated with the risk of all-cause death or hospitalization for acute HF within 24 months after day hospitalization.

CONDITIONS

Official Title

Chronic Heart Failure - COngestion eValuation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with chronic acute heart failure admitted in hospital for scheduled day hospitalization or consultation
  • Age 18 years or older
  • Patients who have received complete information about the study and signed informed consent
  • Patients affiliated with or beneficiaries of a social security scheme
Not Eligible

You will not qualify if you...

  • Life expectancy of 3 months or less due to other illnesses
  • Patients on dialysis or with kidney filtration rate below 15 ml/min/m2
  • History of lung surgery such as lobectomy or pneumonectomy
  • Severe lung or pleural diseases preventing lung ultrasound (e.g., severe emphysema, chronic pleurisy, pulmonary fibrosis)
  • Pregnant, parturient, or nursing women
  • Adults under legal protection measures (guardianship, curatorship, safeguard of justice)
  • Adults unable to give informed consent
  • Persons deprived of liberty by judicial or administrative decision
  • Persons under psychiatric care according to specific public health laws

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHRU de Nancy

Vandœuvre-lès-Nancy, France, 54500

Actively Recruiting

2

CHRU de Nancy

Vandœuvre-lès-Nancy, France, 54500

Not Yet Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here